Browsing by Author Dunger, David B.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2017ACE inhibitors and statins in adolescents with type 1 diabetesDonaghue, Kim; Bond, Simon; Chiesa, S; Dalton, Neil; Daneman, Denis; Dawson, Sarah; Deanfield, John; Dunger, David B.; Jones, Timothy; Mahmud, Farid H.; Marcovecchio, M; Marshall, Sally M.; Neil, H. Andrew W.; Childrens Hospital Westmead: Paediatrics & Child HealthACE inhibitors and statins in adolescents with type 1 diabetes, New England Journal of Medicine, vol.377, 18, 2017,pp 1733-1745
2017Clustering of cardio-metabolic risk factors in parents of adolescents with type 1 diabetes and microalbuminuriaBenitez-Aguirre, Paul; Chiesa, S; Dalton, Neil; Deanfield, John; Dunger, David B.; Fullah, C; Marcovecchio, M; Masi, S; Nguyen, H; Ong, K; Owen, K; Tossavainen, P; Childrens Hospital Westmead: Paediatrics & Child HealthClustering of cardio-metabolic risk factors in parents of adolescents with type 1 diabetes and microalbuminuria, Pediatric Diabetes, vol.18, 8, 2017,pp 947-954
2005Genetic variation in the type 2 insulin-like growth factor receptor gene and disparity in childhood height.Scott, Carolyn; Brown, James; Dunger, David B.; Jones, Yvonne; Ong, Ken K.; Pembrey, Marcus E.; Petry, Clive J.; Wingate, Dianne L.; Northern Clinical School: Molecular Medicine (Kolling I)Genetic variation in the type 2 insulin-like growth factor receptor gene and disparity in childhood height., Growth Hormone & IGF Research, vol.15,(6),2005,pp 363-368
2014Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment - systematic review and modelling of progression and cost-effectivenessWong, Germaine; Clarke, Philip M; Dunger, David B.; et al, Various; Farmer, Andrew; Glasziou, Paul; Hirst, Jennifer; Lung, Tom; Neil, Andrew; Oke, Jason; Stevens, Richard; School of Public Health: Public HealthOptimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment - systematic review and modelling of progression and cost-effectiveness, Health Technology Assessment, vol.18, 14, 2014,pp 1-127